Back to Search Start Over

[A Prognostic Factor Based on Inflammation, Nutrition, and Immune Status for fStage II/III Colorectal Cancer].

Authors :
Yoshimatsu K
Sagawa M
Yokomizo H
Yano Y
Okayama S
Satake M
Matsumoto A
Yamada Y
Asaka S
Usui T
Yamaguchi K
Shiozawa S
Shimakawa T
Katsube T
Naritaka Y
Source :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2017 Oct; Vol. 44 (10), pp. 906-908.
Publication Year :
2017

Abstract

Introduction: We investigated whether the prognostic nutritional index(PNI), controlling nutritional status(CONUT), modified Glasgow prognostic score(mGPS), and the neutrophil count/lymphocyte number ratio(NLR)could be prognostic factors for fStage II/III colorectal cancer.<br />Subjects and Methods: The subjects were 115 patients with fStage II/III colorectal cancer who underwent curative resection. We studied the relationship with 3-year disease-free survival(DFS)and 5-year survival rate(OS).<br />Results: DFS and OS were 75.6% and 84.4%, respectively, and 81.3% and 69.6% for DFS and 82.4% and 84.4% for OS were in fStage II and III, respectively. Univariate analysis of DFS showed significant differences for sex, age, PNI, and NLR, but there was no difference in PS, location, adjuvant chemotherapy, CONUT, or mGPS. In multivariate analysis, sex(male)and NLR(>2)were independent prognostic factors(p=0.006 and p=0.01, respectively). As for OS, although significant differences were recognized for sex, age, PS, PNI, NLR, and CONUT, there was no difference in location, adjuvant chemotherapy, or mGPS. In multivariate analysis, PS(≥1)and NLR(>2)were independent prognostic factors(p=0.009 and p=0.006, respectively).<br />Conclusions: NLR(>2)was an independent prognostic factor for DFS and OS among prognos- tic factors based on inflammation, nutrition, and immunity in fStage II/III colorectal cancer patients.

Details

Language :
Japanese
ISSN :
0385-0684
Volume :
44
Issue :
10
Database :
MEDLINE
Journal :
Gan to kagaku ryoho. Cancer & chemotherapy
Publication Type :
Academic Journal
Accession number :
29066691